Give a concise description of how AZN is financed, with reference to the different sources of capital and gearing levels.

... Give a concise description of how AZN is financed, with reference to the different sources of capital and gearing levels. Analysis of AstraZeneca's (AZN) 2001 annual report1 reveals that the company is financed by all the traditional methods. The sources of finance which are employed to fund AZN operations comprise of;> Creditors due within one year (short-term).> Creditors due after more than one year (long-term).> Capital and reserves (Capital and Reserves). A detailed break down of the sources of finance employed are detailed below in Table 1 'AstraZeneca's Sources of Finance.' and Diagram 1 ' Ratio Analysis of AstraZeneca's Financing.' £m £m £m % % Sources of Finance 2001 2000 Variance Variance Total Financing Creditors due within one year Short term borrowings 150.7 88.7 62.0 41.1% 1.3% Current instalments of loans 75.4 62.0 13.4 17.8% 0.6% Other creditors 4,337.3 4,706.3 -369.0 -8.5% 36.0% 4,563.4 4,857.0 -293.7 -6.4% 37.9% Creditors due after more than one year Loans 447.2 444.4 2.8 0.6% 3.7% Other creditors 107.0 208.5 -101.4 -94.7% 0.9% 554.2 652.8 -98.6 -17.8% 4.6% Capital and reserves Called-up share capital 307.0 311.3 -4.2 -1.4% 2.6% Share premium account 235.2 165.5 69.7 29.6% 2.0% Capital redemption reserve 6.3 2.1 4.2 66.7% 0.1% Merger reserve 304.9 304.9 0.0 0.0% 2.5% Other reserves 1,035.2 1,021.8 13.4 1.3% 8.6% Profit and loss account 5,002.8 4,899.3 103.5 2.1% 41.6% Shareholders' funds - equity interests 6,891.5 6,704.9 186.6 2.7% 57.3% Minority equity interests 25.4 14.8 10.6 41.7% 0.2% Shareholders' funds and minority interests 6,916.9 6,719.7 197.2 2.9% 57.5% Total Financing of AZN 12,034.5 12,229.6 -195.1 -1.6% 100.0% Table 1: AstraZeneca's

want to read more? →